Dr. Chantal Roy-Hewitson, MD
Neurology Physician in Burlington, VT
NPI: 1538330105Primary Practice Location
University of Vermont Medical Center Inc
111 Colchester Ave, Burlington, Vermont, 05401
HQ Phone
Get Dr. Roy-Hewitson's Phone Numberphone_androidMobile
Get Dr. Roy-Hewitson's MobileAbout Dr. Chantal Roy-Hewitson, MD
Technology Used by Dr. Chantal Roy-Hewitson, MD
Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Dr. Chantal Roy-Hewitson, MD Specialties
Dr. Chantal Roy-Hewitson, MD Certifications & Licensure
VT State Medical License
Dr. Chantal Roy-Hewitson, MD Education & Trainingkeyboard_arrow_up
University of Vermont Medical Center
uvmhealth.org
Residency • Neurology
2009 - 2012
Dr. Chantal Roy-Hewitson, MD Top 5 Procedures done in 2025keyboard_arrow_up
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 92 | 145 |
| 2 | G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 83 | 122 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 21 | 55 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 18 | 19 |
Dr. Chantal Roy-Hewitson, MD Publications
Tumor Necrosis Factor Inhibitors as Early Steroid-Sparing Therapy for Neurosarcoidosis: A Case Series.
Authors: Alana Nevares, Jeanne Gosselin
Publication Date: 2024-03-06
Neurosarcoidosis: Phenotypes, Approach to Diagnosis and Treatment.
Authors: Alana Nevares, Bruno Soares, Jeanne Gosselin, Sidarth Dasari
Journal: Curr Rheumatol Rep
Publication Date: 2022-10-12
Recurrent Abducens Palsy in Relapsing-Remitting Multiple Sclerosis.
Authors: Sasikumar, Sanskriti, Roy-Hewitson, Chantal, Geenen, Caroline, Robinson, Dale, Tyndel, Felix
Journal: Can J Neurol Sci
Publication Date: 2020-04-07
Dr. Chantal Roy-Hewitson, MD Clinical Trials1 Clinical Trialkeyboard_arrow_up
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Cladribine